Key facts
- This page summarizes Pascal Touchon's Form 4 filing for Atara Biotherapeutics, Inc. (ATRA).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 18 Nov 2022, 19:13.
Pascal Touchon - 16 Nov 2022 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)
- Signature
- /s/ Jeff Kiekhofer, Attorney-in-Fact for Pascal Touchon
- Issuer symbol
- ATRA
- Transactions as of
- 16 Nov 2022
- Net transaction value
- -$70,004
- Form type
- 4
- Filing time
- 18 Nov 2022, 19:13:47 UTC
- Previous filing
- 18 Aug 2022
- Next filing
- 03 Mar 2023
- SEC filing
- View on sec.gov
Reporting owner
Issuer context
Transaction snapshot
SEC evidence
Key filing fact
Pascal Touchon filed Form 4 for Atara Biotherapeutics, Inc. (ATRA) on 18 Nov 2022.
Change
- Previous filing in this sequence was filed on 18 Aug 2022.
- Current net transaction value: -$70,004.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported transactions
ATRA
transaction
Common Stock
Sale
- Transaction value
- $70,004
- Shares
- -15,591
- Change %
- -3.4%
- Price
- $4.49
- Shares after
- 441,696
- Date
- 16 Nov 2022
- Ownership
- Direct
- Footnotes
- F1, F2
* indicates a reported price that failed the local validity check.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations in connection with the vesting of previously granted restricted stock units. |
| F2 | The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on November 16, 2022 and November 17, 2022 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee. |
Remarks:
Exhibit List: Exhibit 24 - Power of Attorney